CoreValve for High Risk and Extreme Risk Patients; The US Pivotal TrialsPresentaciones24 / 06 / 2015Descargar (PDF, Desconocido)Eduardo de Marchena2014-10-30M.D., F.A.C.C., F.A.C.P., F.S.C.A.I.Professor of Medicine & SurgeryAssociate Dean for International MedicineDirector of Interventional CardiologyUniversity of Miami Miller School of Medicine
Angioplastia con balones liberadores en oclusiones totales crónicas femoropoplíteas: ¿Intraluminal o Subintimal?